Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Nikola Bulj"'
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 6, p 204 (2024)
Cardiac myxomas are the most common benign cardiac neoplasms. Echocardiography is the first-line imaging modality used to analyze cardiac masses, allowing the detection of tumor location, size, and mobility. However, additional imaging techniques are
Externí odkaz:
https://doaj.org/article/556dfd75bce941f2933d2ba7108be41d
Autor:
Josipa Josipović, Livija Šimičević, Živka Dika, Nikola Bulj, Mislav Vrsalović, Bojan Jelaković
Publikováno v:
Acta Clinica Croatica, Vol 62., Iss 2, Pp 313-321 (2023)
Although changes in dietary sodium intake alter blood pressure (BP) in salt-sensitive individuals, pathophysiological mechanisms are still unknown. It has been reported that uromodulin is involved in sodium tubular transport, and genome-wide associ
Externí odkaz:
https://doaj.org/article/85bcb753d0be4a5d802ce06ef836cc52
Autor:
Davor Baric, Nikola Sliskovic, Gloria Sestan, Savica Gjorgjievska, Daniel Unic, Marko Kusurin, Josip Varvodic, Zrinka Safaric Oremus, Ivana Jurin, Nikola Bulj, Dubravka Susnjar, Igor Rudez
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 1, p 17 (2024)
Surgical repair for regurgitant bicuspid aortic valve (BAV) is promising but underutilized due to perceived complexities and lack of long-term data. This study evaluated the efficacy of valve-sparing root remodeling (VSRR) or isolated valve repair co
Externí odkaz:
https://doaj.org/article/bdd968ce800c445694472727ea51ec18
Autor:
Nikola Kos, Ivan Zeljković, Tomislav Krčmar, Karlo Golubić, Fran Šaler, Marijan Erceg, Diana Delić-Brkljačić, Nikola Bulj
Publikováno v:
Cardiology Research and Practice, Vol 2021 (2021)
Aim. The survey’s aim was to examine the significance of infarct-related artery (IRA) occlusion (verified angiographically) on very long-term outcomes of patients with acute myocardial infarction, within the STEMI and NSTEMI diagnosis. Methods. A s
Externí odkaz:
https://doaj.org/article/381ef5a20fdc47ce9cf9ac9e860786cf
Autor:
Ivan Zeljković, Nikola Bulj, Krešimir Kordić, Nikola Pavlović, Vjekoslav Radeljić, Ivica Benko, Ines Zadro Kordić, Kristijan Đula, Nikola Kos, Diana Delić Brkljačić, Šime Manola
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 31, Iss , Pp 100642- (2020)
Background: Although there are numerous studies reflecting predictors of atrial fibrillation (AF) recurrence (AFR) after pulmonary vein isolation (PVI), data on atrial appendages' mechanics is scarce. This study aimed to assess atrial appendages' mec
Externí odkaz:
https://doaj.org/article/2da348baba684243831974d66d24a541
Autor:
Marko Boban, Nikola Bulj, Matea Kolačević Zeljković, Vjekoslav Radeljić, Tomislav Krcmar, Matias Trbusic, Diana Delić-Brkljačić, Tamara Alebic, Aleksandar Vcev
Publikováno v:
Nutrition and Metabolic Insights, Vol 12 (2019)
Nutritional considerations of many chronic diseases are not fully understood or taken into consideration in everyday clinical practice. Therefore, it is not surprising that high proportion of hospitalized patients with cardiovascular diseases remains
Externí odkaz:
https://doaj.org/article/15f242a3b729483f98ffce83385875ba
Autor:
Nikola Kos, Vjekoslav Radeljić, Nikola Pavlović, Krešimir Kordić, Kristijan Đula, Nikola Bulj, Tomislav Krčmar, Diana Delić Brkljačić, Ivan Zeljković, Šime Manola
Publikováno v:
Case Reports in Cardiology, Vol 2019 (2019)
Background. Spontaneous recanalization of a chronically occluded artery is rare and reported anecdotally. Case Summary. We report a case of a patient with a chronically occluded right coronary artery, found on a coronary angiography performed due to
Externí odkaz:
https://doaj.org/article/2f9e0d5bfffb4b1da50750aec71526c7
Publikováno v:
HeartRhythm Case Reports. 9:178-180
Autor:
Kristijan Đula, Ivan Zeljković, Vjekoslav Radeljić, Siniša Car, Mislav Nedić, Nikola Bulj, Diana Delić-Brkljačić
Publikováno v:
Cardiologia Croatica
Volume 17
Issue 9-10
Volume 17
Issue 9-10
Publikováno v:
World Journal of Diabetes
Three major cardiovascular outcome trials (CVOTs) with a new class of antidiabetic drugs - sodium- glucose cotransporter 2 (SGLT2) inhibitors (EMPA-REG OUTCOME trial with empagliflozin, CANVAS Program with canagliflozin, DECLARE-TIMI 58 with dapaglif